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Pharmacovigilance consists in monitoring and preventing the occurrence of adverse
drug reactions. This activity can be time-consuming because it requires the collection
of both patient and medication information. In this paper, we present two visualization
and data mining applications to make this task easier for the practitioner. These
tools have been developed and tested using the biomedical data warehouse eHOP
(Hospital Biomedical Data Warehouse) of the Rennes University Hospital Centre. The
first application is a tool to visualize the patient electronic health record in the form
of a timeline. All patient data is collected and displayed chronologically. The usability
test of the timeline has been very positive (SUS score: 82.5) and the tool is now
available for practitioners in their daily practice. The second application is a tool to
visualize and search the sequences of a patient cohort. The visual interface allow user
to quickly visualize sequences. A query builder allows user to search for sequences in
relation with a reference sequence, such as a prescription sequence followed by an
abnormal biological value. The sequences are then visually aligned with this reference
sequence and ranked by similarity. The GSP (Generalized Sequential Pattern) and Apriori
algorithms allow us to display a summary of the sequences list by searching for common
sequences and associations. The tool was tested on a use case which consisted
in detection of inappropriate drug administration. Compared to a random order, we
showed this ranking system saved the practitioner time in this task (to analyze one
sequence, 3.49 ± 3.54 vs. 2.26 ± 2.86 s, p = 0.0003). These two visualization and
data mining applications will help the daily practice of pharmacovigilance.
Keywords: informatics, graphical user interface, temporal data mining, pharmacovigilance, usability testing
INTRODUCTION
Pharmacovigilance Context
The emergence of clinical data warehouses (CDW) has facilitated the re-use of patient data.
These systems allow exploiting the variety and volume of clinical data. eHOP (Cuggia et al.,
2011) and i2b2 (Murphy et al., 2010) are among the best known CDW examples. Clinical data
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are heterogeneous in terms of structure (structured or textual
data) and domain (e.g., clinical/laboratory results or prescription
data). Searching and organizing such information require
specific expertise and is often a time-consuming task due
to the lack of adapted tools. Data visualization can help to
analyze and develop hypotheses based on massive and complex
data.
Pharmacovigilance is defined by the World Health
Organization as “the science and activities relating to the
detection, assessment, understanding and prevention of adverse
effects and any other drug-related problem” (World Health
Organization [WHO], 2017). Pharmacovigilance includes the
retrospective collection of information from the patients’ medical
records to find clues concerning a drug’s temporal association
with the occurrence of adverse drug reactions (ADRs). This
means finding relevant information in patient records that may
support the ADR occurrence. Therefore, the development of
graphical interfaces connected to CDWs can help to develop
efficient and effective tools for pharmacovigilance activities. This
paper presents two data visualization applications developed
specifically for pharmacovigilance. The first one allows the
chronological visualization of all data of a single patient in
the form of a timeline; the second one is a visualization
and search tool for patient sequences, called “Sequence
Analyzer.”
State of the Art
Several timeline tools for the visualization of electronic
health record (EHR) data to analyze individual clinical data
[e.g., Lifelines (Plaisant et al., 1998), OutFlow (Gotz et al.,
2014), VisuExplore (Rind et al., 2010)] have been described
in the literature. For instance, CareCruiser (Gschwandtner
et al., 2011) provides the simultaneous view of the patient’s
data and therapeutic protocols for the analysis of the
response to treatments (e.g., for a patient on oxygen, the
O2 saturation values will vary depending on the treatment).
VisuExplore (Rind et al., 2010) offers different types of
graphs (distribution curves, histograms), depending on the
data type (e.g., for a diabetic patient, insulin administration
is displayed as dots, while biological parameters, such
as glucose concentration, are displayed as distribution
curves). KNAVE-II (Shahar et al., 2006) is an interactive
and semantic viewer of clinical data based on the use of
domain ontologies. However, none of these tools is specific for
pharmacovigilance.
Many visualization and data-mining tools have been
developed for sequence analysis. EventFlow (Monroe et al.,
2013) allows users to search for exact temporal patterns in a
cohort and to summarize the information in the sequences.
PeerFinder (Du et al., 2017) is a visual interface for finding
similar individuals based on their temporal sequences. OutFlow
(Gotz and Wongsuphasawat, 2012) is a tool to summarize and
visualize the care trajectories of a large number of patients in the
form of advanced Sankey diagrams. However, these tools were
not developed for the specific needs of pharmacovigilance, and




The data used to implement and evaluate our tools came from
eHOP, the CDW technology we developed at Rennes academic
hospital (France) (Cuggia et al., 2011). Briefly, eHOP integrates
all types of documents produced by the hospital information
system and connected with healthcare.
The eHOP CDW currently allows searching among 40
million unstructured data (e.g., clinical narrative notes, surgical
protocols, X-ray, or pathology reports) and 300 million
structured elements (e.g., ICD-10 diagnoses, Anatomical
Therapeutic Chemical terminology for drug prescriptions and
administration) from EHRs, and cover more than 1.2 million
patients. Some unstructured data, such as laboratory results or
diagnoses, are also recorded in a structured form thanks to the
corresponding terminological codes.
Sequence Analyzer
To analyze sequences and develop our interfaces, we defined
a model of patient sequences. Each sequence includes a
chronological series of events (i.e., laboratory results, diagnoses,
medical procedures, the administered dose of a medication). Each
event is defined by a character type, a code, a thesaurus, and a
time stamp. The sequence analysis and results will depend on its
content.
To analyze patient sequences, we used several algorithms.
First, we implemented a modified version of the Smith-
Waterman (SW) (Smith and Waterman, 1981) algorithm because
it allows approximate string matching (also known as fuzzy string
searching) of the reference sequences (query) with all patient
sequences. We introduced modifications in the SW algorithm
to take into account the temporal dimension of the data under
study. We also implemented the Apriori (Srikant and Agrawal,
2018) and GSP (Srikant and Agrawal, 1996) algorithms to search
for associations and common sequence patterns in the patients’
cohort.
Timeline
We designed the timeline based on simple graphic semiology
rules. The visual variables and data types that highlight qualitative
or quantitative differences were based on Bertin’s work (Jacques,
2018). This work proposes rules for data visualization according
to visual variables (forms, colors, surface, etc.). These rules allow
highlighting the data qualitative and quantitative differences.
The development of this timeline was inspired by the timeline
proposed by C. Plaisant’s group in the Inspired EHRs ebook.
We used the VCM language (Inspired EHRs, 2018) to efficiently
represent the data elements in the timeline. This graphical
language, which was developed by J. B. Lamy, represents the
main medical concepts (symptoms, treatments, antecedents of
diseases) with icons and also proposes their alignment with ICD-
10 classification codes (Figure 1). Here, we used this alignment
function to display the ICD-10 data from the PMSI database
(Programme de médicalisation des systèmes d’information;
medicalized information system program) in the timeline.
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FIGURE 1 | Example of VCM icon to describe a cardiac rhythm disorder.
We developed the two prototype graphical user interfaces
(GUIs) as web applications using the JavaScript d3.js (Lamy
et al., 2010) and JQuery libraries for the graphical and interactive
aspects. We designed the prototype components as a web service
written in Java to be weakly coupled to the CDW data source
(eHOP for the prototypes).
Evaluations
Timeline Evaluation
Usability is defined by the International Organization for
Standardization (ISO) as the “extent to which a product
can be used by specified users to achieve specified goals
with effectiveness, efficiency and satisfaction in a specified
context of use” (Bostock, 2017). We chose the ‘think-aloud
protocol’ approach that was described by Nielsen as “the
most reliable evaluation method to obtain a usability estimate”
(ISO, 2017). For this evaluation we recruited six users
(physicians and pharmacists; mean age: 31.3 ± 4.5 years,
range: 25–40) from the Pharmacovigilance Center in Rennes.
Based on literature data, we determined that six people
were sufficient to identify most of the timeline usability
problems (Nielsen, 1993). All routinely used computers for
their pharmacovigilance activity, particularly to study patient
records.
To test all the timeline’s features in a real-life situation, we
chose a use case in collaboration with the Pharmacovigilance
Center head. Specifically, we asked the six users to determine
whether the adverse reaction experienced by a patient admitted
in intensive care was caused by exposure to an antibiotic. To
this aim, they had to perform four main tasks: (i) to find the
patient’s name and address, (ii) to determine the exact nature
of the adverse reaction and collect all pertinent information,
(iii) to find information on the suspected drug (name and
dose, for instance), and (iv) to collect information on the ADR
outcome.
After completing the tasks, each participant had to fill in the
System and Usability Scale (SUS) questionnaire, translated into
French. This questionnaire allows measuring the application’s
usability in a fast and reliable way (Brooke, 1996).
Sequence Analyzer Evaluation
The aim was to evaluate the relevance of our interface for
the identification of sequences that may correspond to cases
of inadequate treatment. For this, we selected hospital stays
from eHOP that included both international normalized ratio
(INR, used to determine the effects of oral anticoagulants)
measurements and vitamin K antagonist (VKA) administrations
(almost 10,000 stays). The aim was to find cases of inappropriate
VKA administration. VKA dosage should be reduced when INR
is higher than the target value (>3). Therefore, we used as query
the reference sequence “INR too high – INR too high – VKA dose
increase” to retrieve patient sequences. Then, two other expert
users (from Rennes Pharmacovigilance Center, but different
from those used for the timeline evaluation) independently
reviewed the retrieved patient sequences to classify them as
corresponding, or not, to a case of inadequate treatment. The
retrieved sequences were displayed first randomly and then as
a sorted list according to their similarity score relative to the
reference sequence.
The two users visualized and analyzed the sequences one
by one, and then reported in a file the sequence identification
number and whether it corresponded to a case of inadequate
treatment. We timed the sequence analysis for each user and
for each method (first random and then sorted list) and tested
the between-method time differences with the Wilcoxon paired
test. We calculated that for a statistical power of 90% with a
type I error of 5% we needed a sample of 80 sequences that
we randomly sampled among the retrieved hospital stays based
on the similarity score against the reference sequence (query)
to select sequences that were equivalently distributed in four
similarity score classes ([100;75], [75;50], [50;25], [25;0]).
RESULTS
Timeline Description
The application provides access to heterogeneous clinical data
information, including the form of free text (hospitalization
reports, discharge letters, etc.), coded using different
terminologies (e.g., the International Classification of
Diseases, 10th revision, ICD-10, medical diagnosis codes),
and structured data (laboratory results, prescriptions and drug
administrations). Each data type has a corresponding visual
representation. The prototype used a web interface to allow
interactive navigation. Real patient data were used to design
and evaluate for the prototype assessment. Figure 2 is a screen
mock-up to show how the information is displayed in the
timeline.
To the best of our knowledge, this application includes
new features. First of them, the possibility of aggregating
Frontiers in Pharmacology | www.frontiersin.org 3 August 2018 | Volume 9 | Article 717
fphar-09-00717 August 29, 2018 Time: 16:27 # 4
Ledieu et al. Time-Related Graphical User Interfaces for Pharmacovigilance
FIGURE 2 | Timeline interface. The interface individual components are: (1) Selection of patient, laboratory, and clinical data and medical codes (e.g., ICD-10 code).
(2) Time scale. (3) Laboratory results in the form of graphic curves (dots show normal values; triangles and their orientation represent anomalous values). (4) Drug
prescriptions and treatment duration (start, end and overall duration time, as well as the drug regimen. (5) Timeline overview for navigation. (6) Overall time period
selection.
structured data. Indeed, in the different medical terminologies,
the information may appear clinically redundant. For example,
at the lowest level of medication classification, Paracetamol
and Doliprane© have two different codes and will therefore
be on two different lines on the timeline (generic and drug
princeps). However, it is the same molecule. The user has
the possibility to aggregate these two data in order to display
it on a single line. This semantic data aggregation/expansion
was implemented by leveraging the hierarchical properties of
different terminologies (Anatomical Therapeutic Chemical, ATC,
classification system; French Common Classification of Medical
Procedures, CCAM; ICD-10; and the local terminology used by
the Clinical Laboratory of Rennes).
This aggregation function is possible for prescriptions,
diagnostics and medical procedures. It allows users to
interactively control the granularity of the information on
the screen.
Another new feature is the display and search in free text.
Free text clinical reports contain a very important source of
information for pharmacovigilance activities. We have developed
document search functions. A free text search field allows user to
search for terms in documents. If a document contains the search
term, its icon on the timeline will be colored blue. If the user clicks
on the complete document, the term in the search field will be
highlighted in the text as shown in the image below (Figure 3).
The content of a document can be visible on a words cloud.
In order to help pharmacovigilants identify the treatments
mentioned in textual records, we have developed NLP module
which automatically extract the drug names from textual
documents. This is particularly useful to find out what treatments
the patient received before his or her stay in hospital, but also to
find out about his or her discharge treatment.
We have also developed the ability to access, directly from the
timeline, a module for visualizing the drug monography. This
makes it easier to retrieve information such as half-life time or
interactions with other drugs to establish the drug’s imputability
for a given side effect.
All these new features were designed to facilitate navigating
through the complexity of patient data.
Timeline Evaluation
The participants’ average SUS score was 82.5 out of 100 points.
After responding to the questionnaire, all participants expressed
the desire to use the timeline in their daily practice. All
participants could successfully perform the tasks required for the
use case.
Sequence Analyzer Description
We developed an application to visualize sequences in a patient
cohort. Unlike other visualization tools, such as PeerFinder
and OutFlow, our tool manages the entire process of data
visualization, from CWD data processing to screen display.
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FIGURE 3 | Timeline interface: Illustration of search Text Feature.
FIGURE 4 | Sequence Analyzer interface: generation of sequence form.
The web interface is divided into two tabs: one for accessing
the sequence extraction interface and the one for viewing the
sequences.
The sequence extraction interface is used to build a cohort of
patient sequences and to choose the methods for data processing
(Figure 4). To build a cohort, the user first creates a list of
concepts by choosing the codes relating to a concept in a tree
structure that gathers several medical terminologies ([1] on
Figure 4). Therefore, a laboratory code and a diagnosis code
can be part of the same concept. Once the list of concepts is
established (INR and VKA in the example in Figure 4), the user
clicks on the “view sets” button ([2] on Figure 4). This action
launches a search among the sets of hospital stays that include the
concepts. The result of this search is displayed as a Venn diagram
with the size of each set ([3] on Figure 4). This visualization
mode is useful for checking whether one or more concepts are
not too discriminating compared with the others. If the user is
satisfied with the size of all sets, he can choose the operations for
processing the data. In the example in Figure 4, these processing
operations concern the numerical values of drug administrations
and of laboratory analysis results. It is possible to discretize data
from user-selected intervals, to calculate the relative or gross
change of a dose or constant between events or during a time
interval ([4] on Figure 4).
The second tab is an interactive visual interface which was
developed to visualize the sequence (Figure 5). A visualization
dictionary has been developed for each type of event ([1]
on Figure 5). For instance, discretized numerical events are
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FIGURE 5 | Sequence Analyzer interface: visualization of sequence.
FIGURE 6 | Smith Waterman Query Builder. The reference sequence includes three too high INR measurements (red squares) followed by an increased VKA dose
administration (red arrow).
represented by a square. Events that describe changes of a
numerical variable are represented by arrows. The direction of
the arrow is based on the trend of the change. Occasional events,
such as a diagnosis, are represented by crosses. Each type of
event has its own color. The stay sequences are represented in
the main part of the interface ([2] on Figure 5). The results of
the GSP and Apriori algorithms, which are respectively the most
common sequences and associations in the cohort ([3] and [4] on
Figure 5), are represented on the right-hand columns.
The user can select the reference sequence(s) to be searched
in a query interface (Figure 6). All event types are listed in the
gray area ([1] in Figure 6). Below this area, each line represents
a search sequence ([2] on Figure 6). The user selects the types
of events present in the gray area by a drag and drop system to
constitute a sequence ([1] on Figure 6). The small spaces to the
left and right of the search sequence are used to specify the time
constraints ([3] on Figure 6).
The search results (Figure 7) are then ranked according to
their similarity with the reference sequence to facilitate their
visualization ([1] in Figure 7). The user can choose to filter the
sequences according to the presence or absence of specific event
types ([2] in Figure 7), or according to the overall duration
of the sequence or the time between the aligned events and
the temporally constrained event ([3] in Figure 7). All of these
criteria can be combined.
The time interval between the alignment and the time
constrained event is indicated by a line showing its duration in
days ([4] on Figure 6). The calculation of the GSP and Apriori
algorithms is restarted with only the sequences filtered, and the
results are updated ([5] on Figure 6).
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FIGURE 7 | Visualization of Smith Waterman results.
Sequence Analyzer Evaluation
User 1’s average analysis time of a sequence was 2.26 ± 2.86 s with
ordered sequences, and 3.49 ± 3.54 s with randomly displayed
sequences (p = 0.0003, Wilcoxon test). For user 2, the average
analysis time of a sequence was 1.06 ± 1.06 s with ordered
sequences, and 1.53 ± 0.85 s with randomly displayed sequences
(p = 0.0001, Wilcoxon test).
DISCUSSION
Timeline Advantages and Limits
The timeline allows to display the contents of the patient file
in a chronological, structured, and concise way. Compared to
the tools presented in the state of the art, the methodological
contribution of the timeline are the following:
• Integration of heterogeneous data with each their
corresponding visual representation (graph for biological
data, VCM icons for diagnosis. . .);
• Data aggregation method based on medical terminologies;
• Method of searching and viewing text data;
• Pharmacology information available : NLP module which
extract the drug names from textual documents and direct link
to drug monography.
These functionalities have been developed specifically according
to pharmacovigilance needs. The text search function makes it
easy to match a medical event mentioned in a document with
the evolution of the biological variable, or a drug administration.
Implementing VCM logos makes it easier to identify diagnostics.
Data aggregation features allow information to be synthesized to
minimize cognitive load by avoiding redundant information.
Other aggregation axes could be evaluated. An aggregation
between semantically and/or temporally close data could also be
considered for example. This would include data that are very
close in time and very similar, like repeated ICD-10 codes for
chronic diseases such as diabetes. A more document oriented
visualization could be proposed. Indeed, it turned out that in use
the return to the text document is systematic to verify the veracity
of the information.
Timeline Evaluation
The SUS score (82.5) and the users’ feedback indicates a good
usability level. This score places the Timeline in the 10% of
applications with usability scores higher than 80 (Sauro and
Lewis, 2012), and is higher than that of the KNAVE-II tool (69.1)
(Martins et al., 2004). The success of all users in the use case
tasks indicates that the timeline is suitable for linking a drug
to an adverse reaction. In addition, the timeline is now used
daily by Rennes Pharmacovigilance Department. However, the
Timeline has not been tested with other use cases and in other
pharmacovigilance services. In addition, it is difficult to quantify
the time savings allowed by the timeline with this usability test.
Indeed, differences in the working method of each participant
have given very variable task completion times. Nevertheless, in
their daily practice, practitioners appreciate the timeline for its
comprehensiveness and ease of access to information.
Sequence Analyzer Advantages and
Limits
Our modified Smith Waterman algorithm has several advantages:
it allows searches for similar sequential patterns. The
modifications we have made allow us to take into account
the time dimension of the data. Other tools (e.g., EventFlow) can
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search for patterns with distant events, but only exact matches.
Another original feature of the tool is that it supports all
the visualization steps: from searching for sequences in the
database, through data processing and transformation, to on-
screen display. All these steps are under user control.
However, in our case study we found that the CDW data
processing step was essential for the sequence search: the
sequences, and thus the patterns founded by algorithms, will
vary depending on the choices made by the user. The input of
experts in the field is essential to generate a sequence suitable
for the research question. If the application allows searching for
sequences in relation to a given pattern, there is not yet any
functionality to group existing sequences together according to
their similarities. Using the patterns found by the GSP algorithm
as vectors, we plan to clusturize the sequences between them
using k-means algorithm.
Sequence Analyzer Evaluation
The Sequence analyzer evaluation showed that the tool allows
retrieving relevant drug administration cases more quickly. This
time saving is made possible by the use of the modified SW
algorithm to take into account the temporal dimension of clinical
data. In addition, the evaluation showed sequences that do not
present the exact pattern of interest may also be relevant. For
example, if we consider the first use case, the pattern “INR too
high” – “INR too high” – “AVK dose administered stable” –
“AVK dose administered increased,” shows an inappropriate
drug administration since the administered dose is not revised
downward. This is an illustration of the relevance of fuzzy
research allowed by the Smith Waterman algorithm. GSP and
Apriori algorithms allow patterns and associations to appear
with a remarkable frequency of appearance. However, we could
not test the data processing part or on another use case. The
application will be tested in a broader usability test to assess
more accurately the relevance of the interface before being made
available to practitioners.
CONCLUSION
The complexity and richness of data found in medical records
require the development of tools for their efficient exploitation,
particularly for viewing and querying information within a file.
The Timeline and Sequence analyzer we developed are viewing
and querying tools dedicated to pharmacovigilance activities.
The timeline demonstrated excellent usability and was used in
daily practice by pharmacovigilance center staff. The second
tool allows exploring a cohort of patients by searching and
visualizing their sequences. The tool has shown its interest in a
performance test in the search for inappropriate prescriptions.
These two tools are expected to help pharmacovigilants in their
daily practice.
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